Connect with us

Health

COVID-19 vaccine efficacy study resumes after participant falls ill – Eyewitness News

The Oxford University randomised control trial, being hosted by Wits University, was temporarily halted last week after a participant in the UK fell ill.

Published

on

post featured image

The Oxford University randomised control trial, being hosted by Wits University, was temporarily halted last week after a participant in the UK fell ill.
CAPE TOWN – More than 1,800 volunteers have been enrolled in Africas first COVID-19 vaccine efficacy study.
The Oxford University randomised control trial, being hosted by Wits University, was temporarily halted last week after a participant in the UK fell ill.
Following an investigation into the UK incident, the vaccine efficacy study ha…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending